Home

Vai al circuito piegato coccodrillo stada arzneimittel investor relations combinazione Fra esegesi

IR Contact - Investor Relations | STADA
IR Contact - Investor Relations | STADA

Annual Report 2022 | STADA
Annual Report 2022 | STADA

News - Investor Relations | STADA
News - Investor Relations | STADA

Annual General Meeting 2020 - Investor Relations | STADA
Annual General Meeting 2020 - Investor Relations | STADA

Press release: Zuellig Pharma becomes STADA Philippines' exclusive  distribution partner | Presseportal
Press release: Zuellig Pharma becomes STADA Philippines' exclusive distribution partner | Presseportal

Annual Report 2022 | STADA
Annual Report 2022 | STADA

STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug |  Investor
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Investor

Hemofarm - News - STADA's 2021 above-market development strengthens base  for further growth, especially in Consumer Healthcare and Specialty
Hemofarm - News - STADA's 2021 above-market development strengthens base for further growth, especially in Consumer Healthcare and Specialty

STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug |  Investor
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Investor

IR Contact - Investor Relations | STADA
IR Contact - Investor Relations | STADA

News - Investor Relations | STADA
News - Investor Relations | STADA

Financial Reports - Investor Relations | STADA
Financial Reports - Investor Relations | STADA

Investor Relations | STADA
Investor Relations | STADA

Investor Relations | STADA
Investor Relations | STADA

Press release : STADA further grows its European Consumer Healthcare  portfolio by ... | Presseportal
Press release : STADA further grows its European Consumer Healthcare portfolio by ... | Presseportal

Hemofarm - News - STADA Health Report 2023: Mental Health of Europeans Is  Improving
Hemofarm - News - STADA Health Report 2023: Mental Health of Europeans Is Improving

Persona che tiene il cellulare con il logo della società tedesca Stada  Arzneimittel AG sullo schermo di fronte alla pagina web aziendale. Messa a  fuoco sul display del telefono Foto stock -
Persona che tiene il cellulare con il logo della società tedesca Stada Arzneimittel AG sullo schermo di fronte alla pagina web aziendale. Messa a fuoco sul display del telefono Foto stock -

Investor Relations | STADA
Investor Relations | STADA

STADA_Press Conference_Invitation_2023.pdf | STADA Arzneimittel AG
STADA_Press Conference_Invitation_2023.pdf | STADA Arzneimittel AG

Financial Reports - Investor Relations | STADA
Financial Reports - Investor Relations | STADA

Corporate Presentation Investor Relations, May 2015
Corporate Presentation Investor Relations, May 2015

Investor Relations | STADA
Investor Relations | STADA

STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug |  Stocks
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Stocks

Hemofarm - News - STADA Health Report: 81 percent of Europeans are open  towards genetic testing
Hemofarm - News - STADA Health Report: 81 percent of Europeans are open towards genetic testing

Press release: STADA ranks among top 10% of pharma firms on sustainability  | Presseportal
Press release: STADA ranks among top 10% of pharma firms on sustainability | Presseportal

Investor Relations | STADA
Investor Relations | STADA

Annual Report 2022 | STADA
Annual Report 2022 | STADA